Intellia Therapeutics 주식 (NASDAQ: NTLA)

에 대한 최신 뉴스 Intellia Therapeutics (NASDAQ:NTLA) 주식

Intellia Therapeutics

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Biotech

Equities

News

Health Care

Markets

ADPT

ARKG

BEAM

CDNA

CRSP

NTLA

RXRX

TWST

VCYT

아크 인베스트의 CEO인 캐시 우드는 인공지능, 유전자 염기서열(시퀀싱) 분석, 유전자 편집 기술의 교차점에서 전례 없는 잠재력을 발견하고 바이오 분야에 투자를 강화하고 있다.

캐시 우드, 바이오 분야에서 4천억 달러 기회 전망

CPRI

MNPR

TSLA

미국 주식 시장은 목요일에 혼조세를 보였다. 나스닥 종합지수는 130포인트 이상 상승한 반면, 다우존스 지수는 0.3% 하락하여 42,374.36으로 마감되었다. S&amp;P 500 지수도 0.2% 상승하여 5,809.86으로 마감했다.

목요일 주목받은 주식: 모노파 테라퓨틱스, 인텔리아 테라퓨틱스, 카프리, 웨스턴 디지털 및 테슬라

ETFs

ACHR

ARKK

AVAV

BLDE

TDOC

VERV

수요일에 캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 이 회사의 인상적인 2분기 납품 실적에 힘입은 최근 상승세에도 불구하고 테슬라(NASDAQ:TSLA)의 상당 수의 주식을 매각하여 주목할만한 움직임을 보였다.

아크 인베스트가 예상을 넘는 2분기 배송 실적에도 $3.25백만 규모 테슬라 주식 매도 추가

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics Inc

InspireMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSPR#NASDAQ">NSPR</a>) reported quarterly losses of $(6.45) per share which beat the analyst consensus estimate of $(9.45) by 31.75 percent. This is a 88.74 percent increase over losses of $(57.30) per share from the same period last year. The company reported quarterly sales of $1.03 million which beat the analyst consensus estimate of $1.00 million by 3.40 percent. This is a 149.16 percent increase over sales of $415.00 thousand the same period last year.

Earnings

Earnings Beats

NSPR

InspireMD Q1 EPS $(6.45) Beats $(9.45) Estimate, Sales $1.03M Beat $1.00M Estimate

Piper Sandler analyst Brent Bracelin maintains Couchbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) with a Overweight and maintains $21 price target.

Price Target

Analyst Ratings

BASE

Piper Sandler Maintains Overweight on Couchbase, Maintains $21 Price Target

A dormant whale resurfaced after 11 years on Tuesday, moving over $250 million worth of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>).
What Happened:&nbsp;According to&nbsp;the on-chain tracking platform Lookonchain, the investor suddenly became active, moving 2,700 BTCs to a new address. The total value of the transferred Bitcoin was estimated to be $257.45 million.
The whale received the stash on Dec. 21, 2013, when Bitcoin was priced at $625.84 per unit. If the transferred amount was intended to be sold, the whale would make a profit of around $255.786 million, representing a staggering 15135.8% return.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">A whale with 2,700 <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a>($257.45M) transferred all 2,700 <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a>($257.45M) out after being dormant for 11 years. The whale received 2,700 <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> on Dec 21, 2013, when the price was $625.84.<a href="https://t.co/cizfddOnn6">https://t.co/cizfddOnn6</a> <a href="https://t.co/E2CXEDaTVK">pic.twitter.com/E2CXEDaTVK</a>
&mdash; Lookonchain (@lookonchain) <a href="https://twitter.com/lookonchain/status/1864118741522632869?ref_src=twsrc%5Etfw">December 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Popular cryptocurrency market observer JA Maartunn also weighed in on the fascinating development, stating that such an event only happened once before. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f6a8; Satoshi, are you there? 2,700 Bitcoin that had been dormant for more than 10 years has just moved. This event has only occurred once before. <a href="https://t.co/FJ0K3kt4yT">pic.twitter.com/FJ0K3kt4yT</a>
&mdash; Maartunn (@JA_Maartun) <a href="https://twitter.com/JA_Maartun/status/1863961195847266750?ref_src=twsrc%5Etfw">December 3, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:&nbsp;<a href="https://www.benzinga.com/24/12/42307265/xrp-becomes-third-most-valued-cryptobeats-boeing-nike-in-market-capitalization">XRP Becomes Third-Most Valued Crypto — Beats Boeing, Nike In Market Capitalization</a>
Why It Matters:&nbsp;The activity of Bitcoin whales often influences the cryptocurrency market. Large transactions can cause significant price fluctuations, either positively or negatively. 
Furthermore, the awakening of dormant whales could indicate that long-term holders are cashing out their Bitcoin holdings.
Data from <a href="https://app.intotheblock.com/">IntoTheBlock</a> concurred with this narrative, showing a dip in the Bitcoin balance held by long-term HODLers.
A 90% spike in Bitcoin&#8217;s exchange net flows also supported the idea that funds were likely getting liquidated.
Price Action: At the time of writing, Bitcoin was exchanging hands at $96,612.29, up 1.25% in the last 24 hours, according to&nbsp;<a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42307586/bitcoin-dumped-and-recovered-in-south-korea-amid-political-turmoil-an-arbitrage-opportunity-that-wasnt">Bitcoin Dumped And Recovered In South Korea Amid Political Turmoil — An Arbitrage Opportunity That Wasn&#8217;t?</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.<a href="https://www.benzinga.com/apis?utm_source=benzinga.com&amp;utm_campaign=article-bottom" rel="noreferrer noopener" target="_blank"></a>
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Dormant Bitcoin Whale Awakens After 11 Years, Moves $257M Worth Of BTC: 'This Event Has Only Occurred Once Before...'

Two people were killed in a fiery Tesla crash in Pelham Manor, New York, on Tuesday, as per reports. 
What Happened: The two people who died are from New Rochelle, CBS News New York <a href="https://www.youtube.com/watch?v=X3HDWa-7SsY">reported</a>, citing sources. 
The Tesla sedan came speeding down Pelhamdale Avenue on Tuesday morning around 9:15 a.m. and smashed into a rock outcropping near the entrance to the New York Athletic Club Travers Island facility, the report said. The vehicle subsequently caught fire. 
The cause of the crash is unclear, the report added. 
Why It Matters: Electric vehicles <a href="https://www.benzinga.com/tech/24/11/42229340/tesla-cybertruck-crash-in-california-claims-3-lives-leaves-1-seriously-injured">pose a risk</a> in case of accidents owing to their lithium-ion batteries. According to the City of New York Fire Department, there were <a href="https://www.benzinga.com/news/24/10/41320744/tesla-crash-kills-4-after-ev-erupts-in-flames">268 fires</a> caused by lithium-ion batteries in 2023 alone.
The fire department did not immediately respond to <a href="https://pro.benzinga.com/dashboard">Benzinga&#8217;s</a> request for a comment on the cause behind the crash on Tuesday.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42308219/ford-uk-chair-calls-on-govt-for-ev-incentives-of-up-to-5000-pounds-per-car-amid-weakening-demand-report">Ford UK Chair Calls For &#8216;Substantial&#8217; Incentives To Boost EV Demand: &#8216;We Need And Want To Sell Electric Vehicles&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Tech

Tesla Car Crash In New York Claims 2 Lives, Cause Unclear: Report

<h3>Companies Reporting Before The Bell</h3>
• Daktronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAKT#NASDAQ">DAKT</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $202.59 million. 
• SecureWorks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWX#NASDAQ">SCWX</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $81.39 million. 
• Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) is expected to report quarterly earnings at $0.40 per share on revenue of $2.00 billion. 
• Thor Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) is projected to report quarterly earnings at $0.72 per share on revenue of $2.23 billion. 
• Dollar Tree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTR#NASDAQ">DLTR</a>) is expected to report quarterly earnings at $1.08 per share on revenue of $7.44 billion. 
• Hormel Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRL#NYSE">HRL</a>) is likely to report quarterly earnings at $0.42 per share on revenue of $3.14 billion. 
• Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) is expected to report quarterly earnings at $0.08 per share on revenue of $2.90 billion. 
• WisdomTree International LargeCap Dividend Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOL#NYSE">DOL</a>) is projected to report quarterly earnings at $0.98 per share on revenue of $1.57 billion. 
• Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) is projected to report quarterly earnings at $2.57 per share on revenue of $2.95 billion. 
• Royal Bank of Canada (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RY#NYSE">RY</a>) is expected to report quarterly earnings at $3.01 per share on revenue of $14.72 billion. 
• Gaotu Techedu (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOTU#NYSE">GOTU</a>) is estimated to report quarterly loss at $0.11 per share on revenue of $172.78 million. 
<h3>Companies Reporting After The Bell</h3>
• Culp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CULP#NYSE">CULP</a>) is likely to report quarterly loss at $0.18 per share on revenue of $58.00 million. 
• DLH Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLHC#NASDAQ">DLHC</a>) is projected to report quarterly earnings at $0.11 per share on revenue of $101.00 million. 
• PVH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) is expected to report quarterly earnings at $2.59 per share on revenue of $2.22 billion. 
• Ooma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OOMA#NYSE">OOMA</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $64.32 million. 
• KNOT Offshore Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNOP#NYSE">KNOP</a>) is projected to report quarterly loss at $0.04 per share on revenue of $73.49 million. 
• ChargePoint Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) is expected to report quarterly loss at $0.09 per share on revenue of $89.58 million. 
• SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) is expected to report quarterly loss at $0.20 per share on revenue of $209.72 million. 
• Sprinklr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXM#NYSE">CXM</a>) is projected to report quarterly earnings at $0.08 per share on revenue of $196.40 million. 
• Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) is projected to report quarterly earnings at $0.16 per share on revenue of $137.38 million. 
• Verint Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRNT#NASDAQ">VRNT</a>) is projected to report quarterly earnings at $0.43 per share on revenue of $210.03 million. 
• Greif (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEF#NYSE">GEF</a>) is projected to report quarterly earnings at $1.10 per share on revenue of $1.41 billion. 
• Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) is likely to report quarterly earnings at $0.17 per share on revenue of $798.58 million. 
• Star Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SGU#NYSE">SGU</a>) is estimated to report earnings for its fourth quarter. 
• AeroVironment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) is likely to report quarterly earnings at $0.68 per share on revenue of $181.44 million. 
• IDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDT#NYSE">IDT</a>) is likely to report earnings for its first quarter. 
• American Eagle Outfitters (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEO#NYSE">AEO</a>) is estimated to report quarterly earnings at $0.46 per share on revenue of $1.30 billion. 
• Container Store Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TCS#NYSE">TCS</a>) is expected to report quarterly earnings at $0.11 per share on revenue of $45.20 million. 
• Synopsys (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) is expected to report quarterly earnings at $3.30 per share on revenue of $1.63 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CHPT

CHWY

CULP

DAKT

DLHC

DLTR

WisdomTree Trust International LargeCap Dividend

FIVE

GSX Techedu Inc. American Depositary Shares

GOTU

KNOP

NCNO

OOMA

SCWX

SNPS

VRNT

Earnings Scheduled For December 4, 2024

Himax Technologies, Inc. ("Himax" or "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIMX#NASDAQ">HIMX</a>) today announced that its Board of Directors has approved a share buyback program. The program authorizes the Company to repurchase up to $20 million of the Company's American Depository Shares ("ADSs") in the open market or through privately negotiated transactions. The program will take effect immediately, does not obligate Himax to repurchase any specific amount of ADSs and may be modified or suspended at the Company's discretion at any time.

Buybacks

HIMX

Himax's Board Approved Up To $20M Share Repurchase Program

William Blair analyst Sarah Schram initiates coverage on Vigil Neuroscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIGL#NASDAQ">VIGL</a>) with a Outperform rating.

Initiation

VIGL

William Blair Initiates Coverage On Vigil Neuroscience with Outperform Rating

The stock market&#8217;s remarkable performance in 2024, with the <a href="https://www.benzinga.com/news/earnings/24/12/42308304/sp-500-hits-another-high-as-apple-tops-242-for-the-first-time-fear-index-remains-in-greed-zone">S&amp;P 500 hitting 54 all-time highs</a>, may not be a positive indicator for the future, according to analysts.
What Happened: The S&amp;P 500&#8217;s record-breaking run in 2024, fueled by factors such as Fed rate cuts, enthusiasm for artificial intelligence, and Donald Trump&#8217;s pro-market policies, has been impressive. However, this trend could be a cause for concern, as historically, years with numerous record highs have been followed by poor stock performance, analysts at Ned Davis Research said in a Monday note.
Historical data since 1928 shows that in years when the S&amp;P 500&nbsp;hit more than 35 record&nbsp;highs, the median gain for&nbsp;the index the following year was a mere 5.8%, falling short of the long-term average of 8%. In years with&nbsp;at least 50 record highs,&nbsp;the median return&nbsp;was -6% the following year.
&#8220;The obvious challenge to momentum studies is that stocks do not go up forever,&#8221; strategists said. 
&#8220;Perhaps AI will drive another productivity and profit boom that will keep inflation and Fed policy benign. History suggests that is the exception rather than the rule.&#8221;
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42286866/shiba-inu-burn-rate-explodes-by-3450-is-shib-price-going-up-72-in-december-again?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Shiba Inu Burn Rate Explodes By 3,450%: Is SHIB Price Going Up 72% In December Again?</a>
There have been exceptions to this trend, such as in 1996 when the S&amp;P 500 returned 20% despite 77 record highs the previous year. However, these gains were largely attributed to the dot-com productivity boom. &#8220;The&nbsp;obvious challenge to momentum studies&nbsp;is that stocks do not&nbsp;go up forever,&#8221; the strategists pointed out.
Other technical indicators also suggest a weaker 2025, with the majority of the stock market&#8217;s gains being concentrated among a handful of companies.
&#8220;Continued narrowing would set the stock market up for a tougher 2025,&#8221; the strategists warned.
Why It Matters: Despite this warning, some analysts remain optimistic about the stock market&#8217;s future.&nbsp;Bank of America analysts&nbsp;have predicted <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42276232/bank-of-america-eyes-sp-500-at-6666-in-2025-we-are-expecting-another-good-year-for-equities">a positive outlook for stocks in 2025</a>, with the S&amp;P 500 Index expected to reach 6,666 by the end of 2025, marking a 10% increase from current levels. This forecast is based on confidence in productivity gains, resilient corporate earnings, and strategic sector rotation.
Furthermore, Ark Invest&#8217;s Cathie Wood has expressed <a href="https://www.benzinga.com/markets/equities/24/12/42262916/ark-invests-cathie-wood-says-stock-market-will-broaden-out-under-trump-but-growth-wont-be-linear-nothing-goes-up-in-a-straight-line">her positive outlook</a> for the stock market under President-elect Donald Trump&#8217;s administration. She believes that the market is already starting to anticipate a shift, indicating potential future growth.
Despite a few dips, the equity markets have been trading higher than the pre-election levels after President-elect Trump&#8217;s victory.
The Dow Jones recorded a gain of 7.5% for November. The S&amp;P 500, reflected in the&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) gained 5.6% last month. The Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which follows the tech-heavy Nasdaq, has posted returns close to 6%.
Meanwhile, the Dow and S&amp;P 500 <a href="https://www.benzinga.com/24/12/42260445/dow-sp-record-best-month-of-year-investor-sentiment-improves-fear-greed-index-remains-in-greed-zone" target="_blank" rel="noreferrer noopener">recorded their best months</a> of the year in November, according to data from <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42296482/xrp-price-explodes-415-in-30-days-experts-analyze-why-xrp-is-going-up?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">XRP Price Explodes 415% In 30 Days: Experts Analyze Why XRP Is Going Up</a></li>
</ul>
Image via Wikimedia Commons

General

S&P 500's Record-Breaking Streak In 2024 Could Signal Caution For Investors In 2025, Warn Analysts: 'Stocks Do Not Go Up Forever'

CNEY

Reported Earlier, CN Energy Receives Extension From Nasdaq To Meet Minimum Bid Price Requirement Until May 2025

Hyatt spotlights ambitious growth strategy in luxury and lifestyle segments, with more focused brand portfolios to unlock the full potential of each brand.

Hyatt Accelerates Expansion In Luxury And Lifestyle Segments With Over 50 New Hotels Set To Open By 2026

<figure class="table"> 
<table>
<tbody>
<tr>
<td>Note</td>
<td>Coupon</td>
<td>Principal</td>
<td>Maturity</td>
<td>Price per Note</td>
<td>Yield to Maturity</td>
</tr>
<tr>
<td>5 year USD notes</td>
<td>5.00%</td>
<td>US$750,000,000</td>
<td>December 15, 2029</td>
<td>US$99.968</td>
<td>5.007%</td>
</tr>
<tr>
<td>10 year USD notes</td>
<td>5.40%</td>
<td>US$750,000,000</td>
<td>December 15, 2034</td>
<td>US$99.837</td>
<td>5.421%</td>
</tr>
<tr>
<td>7 year CAD notes</td>
<td>4.15%</td>
<td>C$500,000,000</td>
<td>December 15, 2031</td>
<td>C$99.836</td>
<td>4.177%</td>
</tr>
</tbody>
</table>
</figure>
&nbsp;

Reported Earlier, Canadian Natural Resources Prices $1.5B In 5- And 10-Year USD Notes And C$500M In 7-Year CAD Notes

Macquarie analyst Paul Golding maintains Iris Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) with a Outperform and raises the price target from $13.5 to $19.

IREN

Macquarie Maintains Outperform on Iris Energy, Raises Price Target to $19

DA Davidson analyst Linda Bolton Weiser maintains Waldencast (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WALD#NASDAQ">WALD</a>) with a Buy and raises the price target from $7.25 to $7.5.

WALD

DA Davidson Maintains Buy on Waldencast, Raises Price Target to $7.5

UBS analyst Tasso Vasconcellos downgrades YPF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YPF#NYSE">YPF</a>) from Buy to Neutral and raises the price target from $30 to $38.

Downgrades

UBS Downgrades YPF to Neutral, Raises Price Target to $38

CTRA

Reported Earlier, Coterra Energy Prices $750M Senior Unsecured Notes Due 2035 At 5.40% And $750M Notes Due 2055 At 5.90%

Jefferies analyst Roger Song maintains Replimune Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REPL#NASDAQ">REPL</a>) with a Buy and raises the price target from $16 to $19.

REPL

Jefferies Maintains Buy on Replimune Group, Raises Price Target to $19

Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) is reportedly facing a delay in its ambitious smart home vision, with a key product now expected to launch in 2025.
What Happened: On Wednesday, analyst Ming-Chi Kuo shared insights indicating that Apple's display-equipped HomePod, a key component of Cupertino&#8217;s strategy, has faced multiple production delays.
According to Kuo, the HomePod&#8217;s mass production was initially set for 2024 but has been postponed to after WWDC 2025, primarily due to software development challenges.&nbsp;
The new HomePod is expected to feature an A18 processor, a 6–7 inch display, and support for Apple Intelligence.
See Also: <a href="https://www.benzinga.com/markets/24/12/42286671/apples-foldable-iphone-could-spark-smartphone-market-revival-in-2026-says-expert?itm_source=parsely-api">Apple&#8217;s Foldable iPhone Could Spark Smartphone Market Revival In 2026, Says Expert</a>
He suggested that this product will mark a strategic shift in Apple&#8217;s HomePod lineup, similar to how the Apple Watch evolved from an iPhone accessory to a health management device.
"The display-equipped HomePod is expected to ship around 500,000 units in 2H25. If the market response is positive, this product's annual shipments could reach the million-unit level," Kuo predicted.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Smart Home Market Becomes Apple's Next Strategic Target; New HomePod with Display Set to Be Key Product in Apple's Smart Home Strategy<a href="https://t.co/smpxEOLb9a">https://t.co/smpxEOLb9a</a>
&mdash; 郭明錤 (Ming-Chi Kuo) (@mingchikuo) <a href="https://twitter.com/mingchikuo/status/1864184005530448366?ref_src=twsrc%5Etfw">December 4, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Previously, it was reported that Apple is working on a new AI wall tablet, <a href="https://www.benzinga.com/media/24/11/41928049/apples-new-ai-wall-tablet-with-siri-and-video-calling-set-to-challenge-amazon-and-google-in-smart-home-race">codenamed J490</a>, which aims to challenge competitors like Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) in the smart home market.
This device, expected to be announced as early as March, will serve as a home command center, integrating AI for app navigation and video calls.
Apple is also reportedly planning to enter the smart home <a href="https://www.benzinga.com/tech/24/11/41891237/apples-smart-camera-coming-in-2026-cupertino-eyeing-tens-of-millions-in-annual-shipments-says-top-supply-chain-analyst">IP camera market in 2026</a>, to achieve tens of millions in annual shipments.
According to Kuo, Apple may integrate this smart camera and HomePod "with its existing ecosystem and HomeKit to deliver a seamless smart home experience."
In October, Apple reported <a href="https://www.benzinga.com/news/earnings/24/10/41666494/apple-q4-earnings-revenue-beat-eps-beat-installed-base-hits-new-highs-iphone-sales-rise-as-apple-in">fourth-quarter revenue</a> of $94.9 billion, surpassing <a href="https://www.benzinga.com/calendars/earnings">analysts&#8217; projections</a> of $94.56 billion. The tech giant also reported adjusted earnings of $1.64 per share for the quarter, exceeding expectations of $1.60 per share.
Price Action: Apple&#8217;s stock rose 1.28% on Tuesday, closing at $242.65, with an additional 0.14% gain in after-hours trading, bringing the price to $243. So far this year, Apple shares have surged 30.71%, outperforming the Nasdaq 100 index, which has climbed 28.32% over the same period, according to <a href="http://pro.benzinga.com/">Benzinga Pro</a>.
Apple's consensus price target is $242.26 from 31 analysts, with the highest at $300 set by Wedbush on Nov. 29. Latest ratings from Wedbush, Morgan Stanley, and Maxim Group average $262.67, suggesting an 8.09% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/AAPL/analyst-ratings"><img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04022256/Screenshot-2024-12-04-at-12.52.51%E2%80%AFPM-1024x380.png" alt="" class="wp-image-675862" /></a></figure>
Check out more of Benzinga's Consumer Tech coverage by <a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42306998/zuckerberg-seeks-active-role-in-trumps-tech-policies-says-metas-president-of-global-affairs-while-admitting-they-overdid-it-a-bit-during-pandemic-content-crackdown?itm_source=parsely-api">Zuckerberg Seeks &#8216;Active Role&#8217; In Trump&#8217;s Tech Policies, Says Top Executive — Admits Meta &#8216;Overdid It&#8217; During Pandemic Content Crackdown</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

AAPL

AMZN

GOOG

GOOGL

Apple HomePod Could Be Delayed Until 2025: Top Analyst Predicts The Device Will Play Key Part In iPhone Maker's 'Smart Home Strategy'

Reported Earlier, Brookdale Chooses Non-Renewal Of Ventas Lease, Aiming For Improved Cash Flow And Shareholder Gains By 2026

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) researcher Troy Teslike said on Tuesday that while the EV giant&#8217;s sales in China are slated to rise this year as compared to the last, sales in the U.S. and Europe will drop, weighing down on the company&#8217;s <a href="https://www.benzinga.com/markets/equities/24/11/42081589/tesla-electric-offers-unlimited-overnight-charging-for-just-5-a-month-as-ev-giant-races-toward-5">overall global deliveries</a>.
What Happened: &#8220;There is no need for celebrations over the China numbers when sales are down in the U.S. and Europe,&#8221; Teslike said. 
While Tesla&#8217;s sales in China are expected to increase by over 48,000 units, sales in the U.S. and Europe are expected to drop by over 30,000 units, Teslike said.
Cybertruck is unlikely to buoy overall sales in the U.S. given that the company is planning a <a href="https://www.benzinga.com/24/12/42283708/tesla-gives-cybertruck-production-line-workers-three-days-off-report">three-day halt in production</a> this month owing to too much inventory, he noted. 
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Based on the latest data, here's the situation for Tesla sales this year across all four quarters compared to last year: • U.S. sales are expected to drop by over 30,000 units. • European sales are also expected to decline by more than 30,000 units. • Meanwhile, China sales…
&mdash; Troy Teslike (@TroyTeslike) <a href="https://twitter.com/TroyTeslike/status/1863963910526661098?ref_src=twsrc%5Etfw">December 3, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: For the full year 2023, Tesla delivered 1,808,581 vehicles around the globe. To mark a growth over last year, the company <a href="https://www.benzinga.com/news/24/10/41443856/tesla-offers-discounts-of-up-to-4k-on-select-model-3-y-vehicles-as-it-looks-to-avert-1st-ever-declin">has to deliver at least 514,926 vehicles</a> in the three months through the end of December.
Tesla has never managed to deliver over 500,000 EVs in a quarter to date, making this an ambitious target.
In the third quarter, Tesla reported deliveries of 462,890 vehicles, up 6.4% year-over-year and up 4.3% quarter-over-quarter.
Deliveries fell 8.5% year-on-year in the first quarter and by 4.8% in the second quarter.
According to Teslike, the <a href="https://www.benzinga.com/tech/24/11/42106067/tesla-registrations-drop-by-over-20-in-october-in-eu-possibly-hindering-its-2024-global-ev-delivery-target" target="_blank" rel="noreferrer noopener">low sales in Europe</a> will likely pull down Tesla&#8217;s global delivery numbers despite a rise in China.
Price Action: Tesla stock closed at $351.42 on Tuesday, down 1.6% for the day. Year-to-date, Tesla&#8217;s shares have risen 41.5%, according to Benzinga Pro data.
Overall, analysts have a consensus rating of &#8220;Buy&#8221; on the Tesla stock, with the highest price target being $411. The most recent analyst ratings by Roth MKM, Stifel, and UBS have an average price target of $339, implying a 3.5% downside.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="471" height="357" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04022334/Tesla-ratings-1.jpg" alt="" class="wp-image-675863" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04022334/Tesla-ratings-1.jpg 471w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/04022334/Tesla-ratings-1-300x227.jpg 300w" sizes="(max-width: 471px) 100vw, 471px" /></figure>
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42283241/gm-to-sell-its-stake-in-jvs-new-battery-cell-plant-in-lansing-to-lg-energy-solution" target="_blank" rel="noreferrer noopener">GM To Sell Stake In Michigan Battery Plant To JV Partner For Nearly $1B</a></li>
</ul>
Photo courtesy: Tesla

Tesla's Global Sales Could Witness A Decline Due To Slowdown In Europe And US, Even As China Set To Rise This Year, Warns Expert

The Company intends to use the net proceeds it receives from the offering to fund a portion of the cash consideration for its recently announced acquisition of Ridgemar (Eagle Ford) LLC (the "Ridgemar Acquisition"), which is expected to close in the first quarter of 2025, subject to customary closing conditions and regulatory approvals

CRGY

Reported Earlier, Crescent Energy Company Prices Upsized Public Offering Of 21.5M Class A Common Shares At $14/Share

The week kicks off amidst significant market movements shaped by geopolitical and policy developments.

From GLD To TSLA: Unlocking Today's Best Trading Opportunities

JMP Securities analyst Silvan Tuerkcan has maintained their neutral stance on NTLA stock, giving a Hold rating today. Silvan Tuerkcan's rating is b...

Intellia Therapeutics: Promising Early Results but Awaiting Late-Stage Validation for Stronger Investment Stance

Intellia Therapeutics' Gene Therapies Fall Short Of Breakthroughs (Rating Downgrade)

Intellia Therapeutics (NTLA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 16. Analyst Mani ...

Intellia Therapeutics' NTLA-2001 Shows Promising Potential with Positive Phase 1 Data and Accelerated Phase 3 Enrollment

Analyst Whitney Ijem of Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NTLA – Research Report), retaining the price target of ...

Positive Buy Rating for Intellia Therapeutics Amid Promising Trial Results for Nex-z in ATTR-CM

20:12 EST Cathie Wood's ARK Investment buys 223.5K shares of Intellia Therapeutics (NTLA) today Published first on TheFly – the ultimate source for...

Cathie Wood's ARK Investment buys 223.5K shares of Intellia Therapeutics today

Pfizer meets amyloidosis rival as BridgeBio wins FDA nod for Attruby

Intellia Therapeutics (NTLA) announced that the U.S. Food and Drug Administration, FDA, has granted Regenerative Medicine Advanced Therapy, RMAT, d...

Intellia announces FDA granted RMAT designation to nexiguran ziclumeran

JonesTrading analyst Debanjana Chatterjee has maintained their bullish stance on NTLA stock, giving a Buy rating on November 18. Debanjana Chatterj...

Promising Outlook for Intellia Therapeutics' Nex-z in ATTR-CM Treatment Backed by Safety and Patient Interest

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:&nbsp...

Biotech Alert: Searches spiking for these stocks today

ALNY

BAYRY

BAYZF

BBIO

CABA

DELL

IONS

OKLO

ONCT

RCAT

REGN

ROOT

SAVA

SRRK

Press Releases

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Intellia Therapeutics Announces Initiation of HAELO Phase 3 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)

Intellia Therapeutics Announces New Date for Upcoming Investor Webcast

Intellia Presents Positive Results from the Phase 2 Study of NTLA-2002, an Investigational In Vivo CRISPR Gene Editing Treatment for Hereditary Angioedema (HAE)

Intellia Therapeutics Announces Two Upcoming Investor Events in November 2024

Intellia Therapeutics Announces Third Quarter 2024 Financial Results and Highlights Recent Company Progress

Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression in Transthyretin (ATTR) Amyloidosis

Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy

Comments

Intellia Therapeutics

뉴스

에 대한 최신 뉴스 Intellia Therapeutics (NASDAQ:NTLA) 주식

수요일, 11월 27, 2024

금요일, 10월 25, 2024

목요일, 7월 04, 2024

목요일, 6월 27, 2024

화요일, 6월 11, 2024

금요일, 6월 07, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌